Legal and General DTR Announc
October 31 2007 - 12:51PM
UK Regulatory
RNS Number:7612G
Hikma Pharmaceuticals Plc
31 October 2007
Notification of major interests in shares
LONDON, 31 October 2007 - Hikma Pharmaceuticals PLC ("Hikma") (LSE: HIK) (DIFX:
HIK), the multinational pharmaceuticals group, announces as follows:
1 Identity of the issuer or the underlying issuer of existing Hikma Pharmaceuticals PLC
shares to which the voting rights are attached
2 Reason for the notification Yes/no
An acquisition or disposal of voting rights Yes
An acquisition or disposal of financial instruments which may result
in the acquisition of shares already issues to which voting rights are
attached
An event changing the breakdown of voting rights
Other (please specify): Compliance with the Transparency Directive
3 Full name of the person subject to the notification Legal & General Group Plc (L&G)
obligation
4 Full name of shareholders if different from above -
5 Date of the Transaction (and date on which the 17 October 2007
threshold crossed is reached differently)
6 Date on which the issuer notified 31 October 2007
7 Threshold that is crossed 3%
8 Notified details
A. Voting rights attached to shares
Class Situation Resulting situation after the triggering transaction
type of previous to
shares the
(if triggering
possible transaction
using Number Number Number of shares Number of voting % of voting
the ISIN of of rights rights
code) shares voting
rights Direct Indirect Direct Indirect Direct Indirect
Ordinary Below Below 5,181,598 5,181,598 3.04%
Shares 3% 3%
B. Financial instruments
Resulting situation after the triggering transaction
Type of Expiration Exercise/ Number of voting rights that may % of
financial Date Conversion be acquired if the instrument if voting
instrument Period/Date exercised/converted rights
Total A+B
Number of Voting rights % of voting rights
5,181,598 3.04%
9 Chain of controlled undertakings through which the voting rights and/or the financial
instruments are effectively held, if applicable
Legal & General Group Plc (Direct and Indirect) (Group)
Legal & General Investment Management (Holdings) Limited
(LGIMH) (Direct and Indirect)
Legal & General Investment Management Limited (Indirect)
(LGIM)
Legal & General Group Plc (Direct) (L&G) (5,181,598 - 3.04% = LGAS, LGPL & PMC)
Legal & General Investment Management Legal & General Insurance Holdings Limited
(Holdings) Limited (Direct) (LGIMHD) (Direct) (LGIH)
Legal & General Assurance (Pensions Legal & General Assurance Society Limited
Management) Limited (PMC) (LGAS & LGPL)
Legal & General Pensions Limited (Direct)
(LGPL)
Proxy Voting
10 Name of the proxy holder N/A
11 Number of voting rights proxy holder will cease to hold N/A
12 Date on which proxy holder will cease to hold voting rights N/A
Additional Information Notification using the total voting rights figure of
170,273,007
Please note this notification has been delayed due
to the large number of disclosures required
following a substantial amount of new business which
has come to us in the form of an in-specie transfer.
13 Contact name Helen Lewis (LGIM)
14 Contact telephone 020 3124 3851
number
- ENDS -
Enquiries:
Hikma Pharmaceuticals PLC
Henry Knowles +44 20 7399 2760
Company Secretary
About Hikma
Hikma Pharmaceuticals PLC is a multinational pharmaceutical group focused on
developing, manufacturing and marketing a broad range of both branded and
non-branded generic and in-licensed pharmaceutical products. Hikma's operations
are conducted through three businesses: Generic, Branded and Injectable
Pharmaceuticals. Hikma's operations are based principally in the United States,
the Middle East and North Africa ("MENA") region and Europe. In 2006, the Group
had revenue of $317 million and profit attributable to shareholders of $54.5
million. For news and other information, please visit www.hikma.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLEAKEFDAFXFFE
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jun 2024 to Jul 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Jul 2023 to Jul 2024